SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?


To: Dr. John M. de Castro who wrote (782)5/18/1999 1:38:00 PM
From: Rick Strange  Read Replies (1) | Respond to of 1386
 
The current Barron's had a story about vision correction surgery using LASERS. The LASIX proceedure requires an incision much like cataract surgery. Barron's states that there were 400,000 of these vision correction procedures last year, 800,000 estimated this year and 2,000,000 by 2003.

Wouldn't this be an excellent additional indication for Lotemax within a high growth area? Maybe someone that has a professional background within the eyecare area would comment.




To: Dr. John M. de Castro who wrote (782)5/26/1999 7:25:00 AM
From: Ariella  Read Replies (2) | Respond to of 1386
 
Hi John -- you'll appreciate the big article on eye laser surgery in this morning's Wall Street Journal. See this line:
<<Optical-industry giant Bausch & Lomb Inc. is seeking Food and Drug Administration approval to introduce its own vision-correcting laser...>>

I leave you to put 2 and 2 together.

;-)
Ariella